Previous Close | 0.0750 |
Open | 0.0605 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.0605 - 0.0978 |
52 Week Range | 0.0600 - 0.2100 |
Volume | |
Avg. Volume | 34,070 |
Market Cap | 12.539M |
Beta (5Y Monthly) | 1.81 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0870 |
Earnings Date | Aug 29, 2022 - Sep 02, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for CLSH
LAS VEGAS, April 05, 2022 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB:CLSH) (CSE:CLSH), the ''Company'' or ''CLS'', a diversified cannabis company operating as Cannabis Life Sciences, will host a webcast on Thursday, April 14, 2022 at 5 p.m. ET to discuss the Company's financial highlights for its third quarter of fiscal year 2022. Event:CLS Holdings USA, Inc. Q3 FY 2022 Financial Results WebcastDate:Thursday, April 14, 2022Time:5:00 p.m. Eastern TimeWebcast:https://onlinexperiences.com/La
LAS VEGAS, NV / ACCESSWIRE / March 15, 2022 / CLS Holdings USA, Inc. (OTCQB:CLSH) (CSE:CLSH), the ''Company'' or ''CLS'', a diversified cannabis company operating as Cannabis Life Sciences, today announced a strong start to the new year with the release of the financial and operational results for its Nevada wholly owned subsidiaries for January and February 2022.
LAS VEGAS, NV / ACCESSWIRE / February 15, 2022 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the ''Company'' or ''CLS'', a diversified cannabis company operating as Cannabis Life Sciences, today announced the financial and operational results for its Nevada wholly owned subsidiaries for the month of January 2022 with net revenues of $1.